$PRAN Headlines U.S. stocks rise; S&P 500, Nasdaq notch

New Post Public Reply Private Reply Replies (0) Message Board

Nov 19, 2014 at 1:57 PM

$PRAN Headlines

U.S. stocks rise; S&P 500, Nasdaq notch quarterly gains 3:47 p.m. March 31, 2014 - Anora Mahmudova
Keurig biggest S&P 500 loser; BlackBerry extends losses 2:30 p.m. March 31, 2014 - Sue Chang
Biotech's shares fall 70% on tests 11:39 a.m. March 31, 2014 - Russ Britt
U.S. stock futures extend gains ahead of Yellen 7:58 a.m. March 31, 2014 - Barbara Kollmeyer
U.S.-listed shares of Prana sink after drug trial 6:50 a.m. March 31, 2014 - Saumya Vaishampayan
Prana sinks 62% after Alzheimer's study fails 6:22 a.m. March 31, 2014 - Barbara Kollmeyer
U.S. stocks edge up; Nasdaq gains for 8th day in a row 4:38 p.m. Feb. 18, 2014 - Anora Mahmudova
Forest Laboratories, Actavis surge on buyout deal 4:11 p.m. Feb. 18, 2014 - Sue Chang
S&P 500, Nasdaq extend win streaks but Dow dips: stock market live blog recap 4:06 p.m. Feb. 18, 2014 - blogs.marketwatch.com
Prana's wild ride continues with shares surging on drug test results 3:24 p.m. Feb. 18, 2014 - Russ Britt
Prana's Huntington disease therapy meets endpoints 11:51 a.m. Feb. 18, 2014 - MarketWatch.com
Prana Biotechnology up 19% in premarket 8:58 a.m. Dec. 6, 2012 - Steve Gelsi
Prana has OK for Alzheimer's study; shares rise 1:30 p.m. Nov. 22, 2011 - MarketWatch.com
Monday’s biggest gaining and declining stocks 3:30 p.m. Sept. 19, 2011 - Laura Mandaro
Prana, European drug makers lead rally 2:26 p.m. April 20, 2011 - Val Brickates Kennedy
Prana climbs 14% on business update 10:18 a.m. April 20, 2011 - Val Brickates Kennedy
Xoma, Prana lead biotech stocks south 12:19 p.m. March 23, 2011 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 3:56 p.m. March 22, 2011 - Kate Gibson
Prana shines in drugstock trading 10:02 a.m. March 22, 2011 - Val Brickates Kennedy
Prana rockets on Alzheimer's study 9:20 a.m. March 22, 2011 - Val Brickates Kennedy

Genervon ALS drug shows encouraging results 7:27 a.m. Oct. 20, 2014 - Seeking Alpha
Horizon Pharma's Actimmune Gets Orphan Drug Designation - Analyst Blog 1:00 p.m. Oct. 7, 2014 - Zacks.com
Prana Biotechnology Up on Orphan Drug Status for PBT2 - Analyst Blog 4:35 p.m. Sept. 8, 2014 - Zacks.com
Why Prana Biotechnology (PRAN) Stock Is Surging Today 8:46 a.m. Sept. 5, 2014 - TheStreet.com
Why Prana Biotechnology (PRAN) Stock Is Surging Today 1:05 p.m. July 17, 2014 - TheStreet.com
Prana shares up premarket on clinical trial update 8:22 a.m. July 17, 2014 - Seeking Alpha
Prana Biotechnology (PRAN) Stock Suddenly Surges 2:28 p.m. May 27, 2014 - TheStreet.com
Prana Biotechnology Is Still A Short After Recent Alzheimer's Failure 3:15 p.m. April 14, 2014 - Seeking Alpha
Are These Three Biotech Companies Still Worth A Gamble? 10:16 a.m. April 14, 2014 - Seeking Alpha
Prana collapses after trial fails 5:57 a.m. March 31, 2014 - Seeking Alpha
Prana Biotechnology - A Gamble Worth Taking For Both Long- And Short-Term Investors 2:49 p.m. March 20, 2014 - Seeking Alpha
Prana to join Aussie index for top 300 companies 9:00 a.m. March 11, 2014 - Seeking Alpha
Alzheimer's Research Stocks - Technical And Other Considerations 8:38 a.m. March 7, 2014 - Seeking Alpha
Prana Biotech Alzheimer approach supported by study 10:49 a.m. March 6, 2014 - Seeking Alpha
Alzheimer's Dementia: Eli Lilly's Solanezumab Or Prana's PBT2, Which Would You Take? 3:24 p.m. March 4, 2014 - Seeking Alpha
Prana: Right Drug, Wrong Dose 9:38 a.m. March 3, 2014 - Seeking Alpha
Bipolar Prana: PBT2 For Alzheimer's Dementia, Implications Of The Upcoming IMAGINE Trial Results 6:45 a.m. March 1, 2014 - Seeking Alpha
Following The Latest In Alzheimer's Research As An Investor 10:12 a.m. Feb. 24, 2014 - Seeking Alpha
Positive Phase 2 Results For Prana Biotechnology In Huntington's Disease: Behind The Smoke And Mirrors 12:45 p.m. Feb. 22, 2014 - Seeking Alpha
SA PRO: Top Long And Short Ideas, Thursday February 20 7:30 a.m. Feb. 21, 2014 - Seeking Alpha

The Lancet Neurology Publishes Prana's Huntington Disease Trial 11:01 a.m. Today - BusinessWire - BZX
Analyst Scanner on Biotech Equities - Prana Biotechnology, CytRx, Insmed, Dynavax Technologies, and Vertex Pharma 8:15 a.m. Sept. 11, 2014 - PR Newswire - PRF
Prana receives FDA Orphan Drug Designation for PBT2 for Huntington Disease 6:45 a.m. Sept. 5, 2014 - PR Newswire - PRF
Prana Alzheimer's disease Development Program update 3:10 p.m. July 17, 2014 - PR Newswire - PRF
Biotech Equities Technical Momentum -- Research on Organovo, Prana Biotechnology, Isis Pharma, and Pharmacyclics 6:04 a.m. July 14, 2014 - PR Newswire - PRF
Executive Appointments and Technical Updates - Analyst Notes on Aeri Pharmaceuticals, DaVita, Prana Biotechnology, Raptor and Avanir Pharmaceuticals 4:10 a.m. July 14, 2014 - PR Newswire - PRF
Stock Watchout on Biotech Industry -- Research on Isis Pharma, Pharmacyclics, Amarin, and Prana Biotechnology 6:10 a.m. June 11, 2014 - PR Newswire - PRF
Biotech Equities Coverage -- Research on Isis Pharma, Pharmacyclics, Prana Biotech, and United Therapeutics 10:29 a.m. May 19, 2014 - PR Newswire - PRF
World leader in movement disorders Professor Ira Shoulson joins Prana Board 6:30 a.m. May 14, 2014 - PR Newswire - PRF
Technical Report on Top Gainers -- Research on Centene, Prana Biotechnology, Horizon Pharma, and Scientific Games 10:34 a.m. April 23, 2014 - PR Newswire - PRF
Zeldes Haeggquist & Eck LLP Announces Investigation of Prana Biotechnology Limited 8:03 a.m. April 23, 2014 - BusinessWire - BZX
Prana Biotechnology Stock Hits New Low 9:47 a.m. April 16, 2014 - ACCESSWIRE
FDA Panel Grants Market Approval of MannKind Corp.'s Inhalable Insulin 8:49 a.m. April 2, 2014 - ACCESSWIRE
Coca-Cola Falls as Soda Sales Drop for 9th Straight Year 1:00 a.m. April 1, 2014 - ACCESSWIRE
Prana Biotechnology announces preliminary results of Phase 2 IMAGINE trial of PBT2 in Alzheimer's disease 6:05 a.m. March 31, 2014 - PR Newswire - PRF
Biotech Equities Technical Study -- Research on Prana Biotechnology, Amarin, United Therapeutic, and OPKO Health 11:19 a.m. March 28, 2014 - PR Newswire - PRF
Huntington's Reviewed by NeuroPerspective 8:30 a.m. March 4, 2014 - PR Newswire - PRF
Forest Labs to be acquired by Actavis for $25 billion while Prana Biotech surges on drug results 12:23 a.m. Feb. 19, 2014 - ACCESSWIRE
Prana Meets Primary Endpoint in Phase 2 REACH2HD Clinical Study of PBT2 for Treating Huntington Disease 6:02 a.m. Feb. 18, 2014 - PR Newswire - PRF
Products Recall, Stock Price Updates, Technology Solution Deployment, Update on Extension Trial, and Donations - Research Report on Alexion Pharma, Questcor, BioMarin Pharma, Allscripts, and Prana 8:00 a.m. Dec. 20, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ECRI Welcomes Safety Expert Meshkati to Its Board

The Safety Maverick Steps into Healthcare They've gone and done it—appointed a rockstar of systems safety to ECRI's Board of Trustees. Professor Najmedin Meshkati, who's practically been around every major industrial accident of the past few decades, is about to shake things up. Imagine the guy who's dissected calamities like the BP Texas City Refinery explosion and the...

Argo Biopharma's BW-20805 Shows Promise in HAE Phase II Trial

Argo's Gains in Hereditary Angioedema Therapy Think about it, folks – reducing a hereditary angioedema attack by over 80%? Argo Biopharma, the slick operator in the RNA therapeutics space, is flexing its muscles again. They've hauled in some impressive data for their siRNA therapeutic, BW-20805, at the 2026 Bradykinin Symposium in Berlin. For you deep-pocketed investors...

Regeneron: Investors Face Class Action Over Study Flaws

Regeneron Investors Grit Teeth Amid Lawsuit Drama The gloves are off in the pharmaceutical battleground, folks. Investors who thought they were riding the big wave with Regeneron Pharmaceuticals (NASDAQ: REGN) are now staring down the barrel of a class action lawsuit. It seems the company’s been caught in a storm of legal action following allegations of misleading...

Aurzen Leverages Basquiat for Art-Infused Projection Line

A Fresh Perspective on Portable Projection If anyone had told me a tech brand would buddy up with the world of fine art to launch a new gadget line, I'd have raised an eyebrow. But here we are, shrugging away the standard and looking at what's cooking over at Aurzen. The company's new initiative, 'Unfold the Art,' marries the magnetism of Jean-Michel Basquiat's artwork...

Windows Storage Trends Shift: SSD Dominates 2026

SSDs Take Center Stage in Storage Evolution Howdy, storage folks! It's 2026, and one thing's for sure—SSDs are strutting their stuff at the top of the storage heap. According to the latest report by EaseUS Software, the dominant drive isn't about sheer size anymore. We've moved on to smarter space management. Now hear this: 79.73% of Windows system drives are rocking...

PinkBlush Maternity Unveils Its 2026 Fall Fashion Line

Elevating Maternity Fashion with PinkBlush's Fall 2026 Line You know, it's not every day you see maternitywear aiming to push the envelope, but that's exactly what PinkBlush is doing this fall. They've unleashed their Fall 2026 collection, and let's just say, it's less about the frills and more about redefining what expecting mothers can expect from the fashion world. A...

Ed Markey's Political Future on Shaky Ground in MA

Massachusetts Voters Voice Desire for Change Ever seen an old engine stutter and cough before finally quitting? That's what Ed Markey's political career is starting to feel like. A fresh poll has surfaced, casting doubt over his steady grip on his longstanding Senate seat in Massachusetts. People are yearning for fresh faces and new ideas like never before. It's as if the...

Reolink Unveils OMVI 2i Ultra at IFA 2026

Reolink's Bold Move Into the Future of Home Security Amidst the hustle of Berlin's IFA 2026, Reolink dropped its latest gem: the OMVI 2i Ultra—an all-in-one security powerhouse promising to change the game for home protection junkies. As usual, Reolink's got its eyes on the prize, pushing boundaries with this latest lineup. OMVI 2i Ultra: Dual-View Revolution If you've...

Baidu Joins Shanghai-HK Connect, Expanding Reach

Big News from Baidu: Connect Program Inclusion Bet you didn't see this one coming. Baidu, the titan of AI in China, just rolled out some significant buzz. Starting September 7th, their Class A ordinary shares will join the Shanghai-Hong Kong Stock Connect program, shaking things up on the Shanghai Stock Exchange. This move is set to give investors from the Chinese...

ACEMAGIC Unveils New AI Mini Workstation at IFA 2026

A Glimpse Into ACEMAGIC's Latest Innovation Look if you had told me five years ago that AI mini workstations would be making waves, I'd have probably smirked. Yet, here we are; ACEMAGIC is setting the stage at IFA 2026 in Berlin with their fresh-out-the-oven F9A AI mini workstation, powered by AMD's Ryzen AI Max+ PRO 495 processor. It all goes down from September 4 to 8...